Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2016


#515511

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Hormone Refractory Prostate Cancer. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metastatic Hormone Refractory Prostate Cancer. DelveInsights Report also assesses the Metastatic Hormone Refractory Prostate Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope

Table of Contents
Metastatic Hormone Refractory Prostate Cancer Overview
Metastatic Hormone Refractory Prostate Cancer Pipeline Therapeutics
Metastatic Hormone Refractory Prostate Cancer Therapeutics under Development by Companies
Metastatic Hormone Refractory Prostate Cancer Filed and Phase III Products
Comparative Analysis
Metastatic Hormone Refractory Prostate Cancer Phase II Products
Comparative Analysis
Metastatic Hormone Refractory Prostate Cancer Phase I and IND Filed Products
Comparative Analysis
Metastatic Hormone Refractory Prostate Cancer Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
Metastatic Hormone Refractory Prostate Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Metastatic Hormone Refractory Prostate Cancer Discontinued Products
Metastatic Hormone Refractory Prostate Cancer Dormant Products
Companies Involved in Therapeutics Development for Metastatic Hormone Refractory Prostate Cancer
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Metastatic Hormone Refractory Prostate Cancer, 2016
Number of Products under Development by Companies
Comparative Analysis by Filed and Phase III Products, 2016
Comparative Analysis Phase II Products, 2016
Comparative Analysis Phase I and IND Filed Products, 2016
Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
Drug Candidates Profiles
Metastatic Hormone Refractory Prostate Cancer Assessment by Monotherapy Products
Metastatic Hormone Refractory Prostate Cancer Assessment by Combination Products
Metastatic Hormone Refractory Prostate Cancer Assessment by Route of Administration
Metastatic Hormone Refractory Prostate Cancer Assessment by Stage and Route of Administration
Metastatic Hormone Refractory Prostate Cancer Assessment by Molecule Type
Metastatic Hormone Refractory Prostate Cancer Assessment by Stage and Molecule Type
Metastatic Hormone Refractory Prostate Cancer Therapeutics Discontinued Products
Metastatic Hormone Refractory Prostate Cancer Therapeutics Dormant Products
Products under Development by Companies, 2016

List of Figures
Number of Products under Development for Metastatic Hormone Refractory Prostate Cancer, 2016
Filed and Phase III Products, 2016
Phase II Products, 2016
Phase I and IND Filed Products, 2016
Discovery and Pre-Clinical Stage Products, 2016
Metastatic Hormone Refractory Prostate Cancer Assessment by Monotherapy Products
Metastatic Hormone Refractory Prostate Cancer Assessment by Combination Products
Metastatic Hormone Refractory Prostate Cancer Assessment by Route of Administration
Metastatic Hormone Refractory Prostate Cancer Assessment by Stage and Route of Administration
Metastatic Hormone Refractory Prostate Cancer Assessment by Molecule Type
Metastatic Hormone Refractory Prostate Cancer Assessment by Stage and Molecule Type